Capabilities
Non-Sterile Manufacturing
KEY NUMBERS
5,000 GAL
Batch Liquid
Manufacturing Capacity
1,000 GAL
Batch Semi-solid
Manufacturing Capacity
R&D, manufacturing, packaging, and warehousing of non-sterile liquids and semi-solids from TriRx’s best-in-class pharmaceutical facilities in Segré, Speke, Huntsville, and Shawnee.
TriRx offers flexible contract pharmaceutical manufacturing services for non-sterile liquid and semi-solid Rx and OTC products from FDA-approved and GXP-compliant facilities in North America and Europe.
Our non-sterile manufacturing teams are well versed in the unique characteristics of liquid solutions and suspensions and semi-solid drug products, with great experience in the intricate processes required to maintain their structural properties throughout the manufacturing process and beyond. This specialized expertise translates to a stable and high-quality product from lab to commercial scale.
Our Huntsville facility in Alabama offers large-scale production of solutions, suspensions, creams, lotions and ointments in a 197,000 ft2 facility combining R&D, manufacturing, packaging and warehousing. This development & pharmaceutical manufacturing facility is designed and approved to handle controlled substances (CII – CV). Packaging lines are fully serialized and offer a variety of bottle sizes.
Our FDA-approved and GMP-compliant Shawnee, Kansas facility offers animal health and human health product manufacturing and packaging services of non-sterile liquids, oral solid dose, and topicals. The more than 210,000m2 facility has an excellent compliance record. Shawnee produces high-volume non-sterile liquids, pastes, tableting, along with chewable products.
Segré in France is a former manufacturing facility that offers non-sterile compounding of solutions, suspensions and ointments. We fill liquids into small and large bottles and ointments into plastic or glass vials. Pharmaceutical manufacturing, filling and secondary packaging are integrated at a site that is located in a major biopharmaceutical hub, making it easily accessible for you while offering an exceptional compliance record for your animal health drug products.
The Speke facility is positioned in the center of one of the UK’s leading bioprocessing regions. It is an FDA-, MHRA-, FAMI-QS, and SFSF-approved facility offering robust human and animal health capabilities, including biotech API production, fermentation and downstream processing, spray drying and coating, pre-mixing, and non-sterile liquid filling. More than 320 employees working at the Speke site produce over 135 SKUs, directly supplying in excess of 65 global customers.
LIQUIDS & SEMI-SOLID MANUFACTURING
- Large-scale non-sterile manufacturing
- Solutions, suspensions and colloidal dispersions
- Creams, ointments and lotions
- Liquid and ointment compounding
- Filling of small and large bottles
- Supplying both OTC and Rx products